Revenue growth – what the numbers mean
The Sonendo Q2 2025 release does not list the actual revenue figures in the excerpt you provided, so a precise YoY (year‑over‑year) and QoQ (quarter‑over‑quarter) growth rate cannot be calculated from the information at hand. If the full press release or the SEC Form 10‑Q shows the total revenue for Q2 2025, the YoY growth would be:
[
\text{YoY %} = \frac{\text{Q2 2025 Revenue} - \text{Q2 2024 Revenue}}{\text{Q2 2024 Revenue}} \times 100\%
]
and the QoQ growth would be:
[
\text{QoQ %} = \frac{\text{Q2 2025 Revenue} - \text{Q1 2025 Revenue}}{\text{Q1 2025 Revenue}} \times 100\%
]
Trading implications
- If YoY is strong (e.g., >10 %): The market is likely rewarding Sonendo’s expanding dental‑technology franchise, and the stock could see upside on momentum. A bullish entry on pull‑backs to the 20‑day moving average would be reasonable, with a stop just below the recent low‑volume support zone.
- If QoQ is modest or flat: The company may be in a seasonal pause, suggesting a more cautious stance. In that case, consider a “wait‑and‑see” approach—hold existing positions but avoid adding on breakout‑biased entries until the next earnings beat.
Action step
Locate the complete earnings release (or the 10‑Q filing) to pull the exact Q2 2025, Q2 2024, and Q1 2025 revenue numbers. Plug those into the formulas above, then compare the resulting growth rates to analyst consensus and sector peers. A YoY out‑performance paired with a solid QoQ uptick would justify a short‑to‑mid‑term long bias, while weak or negative growth would warrant a defensive posture or a potential short‑side consideration.